Collectively, these results suggested that the canonical Wnt/β-catenin pathway is hyperactivated in oxaliplatin-resistant CRC cells, and a reciprocal positive regulatory mechanism exists between Wnt/β-catenin and IMPDH2. This evidence concerns the gene IMPDH2 and colorectal carcinoma.